{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:13:52Z","timestamp":1770815632789,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Densitometry"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.jocd.2013.12.001","type":"journal-article","created":{"date-parts":[[2014,3,5]],"date-time":"2014-03-05T22:15:41Z","timestamp":1394057741000},"page":"484-489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Cost-Minimization Study Comparing Annual Infusion of Zoledronic Acid or Weekly Oral Alendronate in Women With Low Bone Mineral Density"],"prefix":"10.1016","volume":"17","author":[{"given":"Venice","family":"Ch\u00e1vez-Valencia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9sar Alejandro","family":"Arce-Salinas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabricio","family":"Espinosa-Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocd.2013.12.001_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/rheumatology\/40.1.7","article-title":"On conducting burden-of-osteoporosis studies: a review of the core concepts and practical issues. A study carried out under the auspices of a WHO Collaborating Center","volume":"40","author":"Sedrine","year":"2001","journal-title":"Rheumatology"},{"key":"10.1016\/j.jocd.2013.12.001_bib2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1359\/jbmr.061113","article-title":"Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025","volume":"22","author":"Burge","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2013.12.001_bib3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/pmj.79.929.133","article-title":"What is osteoporosis?","volume":"79","author":"Chistodoulou","year":"2003","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jocd.2013.12.001_bib4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrrheum.2009.260","article-title":"Osteoporosis: impact on health and economics","volume":"6","author":"Harvey","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jocd.2013.12.001_bib5","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1007\/s00198-005-1991-4","article-title":"Incidence rates and life-time risk of hip fractures in Mexicans over 50 years of age: a population-based study","volume":"16","author":"Clark","year":"2005","journal-title":"Osteoporos Int"},{"issue":"2A Suppl","key":"10.1016\/j.jocd.2013.12.001_bib6","first-page":"S25","article-title":"The socioeconomic burden of fractures: today and in the 21st century","volume":"103","author":"Johnell","year":"1997","journal-title":"Am J Med"},{"key":"10.1016\/j.jocd.2013.12.001_bib7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1699-258X(08)72460-4","article-title":"Perspectives on osteoporosis in developing countries: growing problem, dwindling resources","volume":"4","author":"Morales-Torres","year":"2008","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.jocd.2013.12.001_bib8","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s001980050107","article-title":"The cost of treating osteoporotic fractures in the United Kingdom female population","volume":"8","author":"Dolan","year":"1998","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2013.12.001_bib9","series-title":"Clinician's guide to prevention and treatment of osteoporosis","year":"2010"},{"key":"10.1016\/j.jocd.2013.12.001_bib10","doi-asserted-by":"crossref","first-page":"404","DOI":"10.7326\/0003-4819-149-6-200809160-00007","article-title":"Pharmacologic treatment of low bone density or osteoporosis to prevent fractures: a clinical practice guideline from the American College of Physicians","volume":"149","author":"Qaseem","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jocd.2013.12.001_bib11","first-page":"235","article-title":"Recommendations for osteoporosis management","volume":"140","author":"Z\u00e1rate","year":"2004","journal-title":"Gac Med M\u00e9x"},{"key":"10.1016\/j.jocd.2013.12.001_bib12","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJM199511303332201","article-title":"Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis","volume":"333","author":"Liberman","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocd.2013.12.001_bib13","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jocd.2013.12.001_bib14","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis. A randomized controlled trial","volume":"282","author":"Harris","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jocd.2013.12.001_bib15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJM200102013440503","article-title":"Effect of risedronate on the risk of hip fracture in elderly women","volume":"344","author":"McClung","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocd.2013.12.001_bib16","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1359\/JBMR.040325","article-title":"Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis","volume":"19","author":"Chesnut","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2013.12.001_bib17","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocd.2013.12.001_bib18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/1471-2474-12-209","article-title":"The relative efficacy of osteoporosis medications for reducing the rate of fractures in post-menopausal women","volume":"12","author":"Hopkins","year":"2011","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.jocd.2013.12.001_bib19","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/bmj.307.6905.670","article-title":"What does it mean?","volume":"307","author":"Robinson","year":"1993","journal-title":"BMJ"},{"key":"10.1016\/j.jocd.2013.12.001_bib20","unstructured":"Wilson K, Smith A. Monitoring BMD with DXA: short- and long-term precision W-157 1\/06 USA\/International. Bedford, MA: Hologic, Inc., 2006."},{"key":"10.1016\/j.jocd.2013.12.001_bib21","unstructured":"Updated Official Positions of the International Society of Clinical Densitometry. Available at: www.iscd.org\/documents\/2013\/07\/2013-iscd-official-positions-adult.pdf. Accessed December 2, 2013."},{"key":"10.1016\/j.jocd.2013.12.001_bib22","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(02)08761-5","article-title":"Diagnosis of osteoporosis and assessment of fracture risk","volume":"359","author":"Kanis","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jocd.2013.12.001_bib23","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0140-6736(01)06107-4","article-title":"Introduction to health economics for physicians","volume":"358","author":"Meltzer","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jocd.2013.12.001_bib24","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00198-007-0506-x","article-title":"Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women","volume":"19","author":"Rabenda","year":"2008","journal-title":"Osteoporos Int"},{"issue":"3 Suppl","key":"10.1016\/j.jocd.2013.12.001_bib25","first-page":"604","article-title":"Medical possession ratio and efficacy between zoledronic acid or weekly alendronate at one year, in post-menopausal women with low bone density","volume":"69","author":"Ch\u00e1vez-Valencia","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jocd.2013.12.001_bib26","first-page":"167","article-title":"The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation","volume":"30","author":"Bruce","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jocd.2013.12.001_bib27","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1136\/bmj.285.6346.949","article-title":"What is economics?","volume":"285","author":"Mooney","year":"1982","journal-title":"BMJ"},{"key":"10.1016\/j.jocd.2013.12.001_bib28","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1136\/bmj.307.6906.726","article-title":"Costs and cost-minimisation analysis","volume":"307","author":"Robinson","year":"1993","journal-title":"BMJ"},{"key":"10.1016\/j.jocd.2013.12.001_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0266462305050014","article-title":"Health-care decision-making processes in Latin America: problems and prospects for the use of economic evaluation","volume":"21","author":"Iglesias","year":"2005","journal-title":"Int J Technol Asess Health Care"},{"key":"10.1016\/j.jocd.2013.12.001_bib30","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1590\/S0036-36342009000700014","article-title":"Direct costs of osteoporosis and hip fracture: an analysis for the Mexican Social Insurance Health Care System","volume":"51","author":"Carlos","year":"2009","journal-title":"Salud Publica Mex"},{"key":"10.1016\/j.jocd.2013.12.001_bib31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3111\/13696998.2010.545563","article-title":"The cost effectiveness of zoledronic acid 5 mg for the management of postmenopausal osteoporosis in women with prior fractures: evidence from Finland, Norway and the Netherlands","volume":"14","author":"Akehurst","year":"2011","journal-title":"J Med Econ"},{"key":"10.1016\/j.jocd.2013.12.001_bib32","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1200\/JCO.1984.2.3.187","article-title":"Karnofsky performance status revisited: reliability, validity, and guidelines","volume":"2","author":"Schag","year":"1984","journal-title":"J Clin Oncol"}],"container-title":["Journal of Clinical Densitometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695013002126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695013002126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:39:35Z","timestamp":1761082775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094695013002126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S1094695013002126"],"URL":"https:\/\/doi.org\/10.1016\/j.jocd.2013.12.001","relation":{},"ISSN":["1094-6950"],"issn-type":[{"value":"1094-6950","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-Minimization Study Comparing Annual Infusion of Zoledronic Acid or Weekly Oral Alendronate in Women With Low Bone Mineral Density","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Densitometry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocd.2013.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The International Society for Clinical Densitometry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}